Your Next Profit Opportunity is Just Around the Corner
Don’t sit around waiting for the next short squeeze to boom. Here’s where the next payday could come from.
Much of the attention surrounding short squeezes has been on the two big names over the last few weeks.
Massive surges from the two stocks that started the short squeeze craze have re-ignited retail investors’ interest in hunting short positions for big gains – and has resulted in a flood of money pouring back into short squeeze plays.
Since May 20, GameStop Corp. (GME) has risen by 94% at its highest point.
In the same timeframe AMC Entertainment Holdings, Inc. (AMC) has seen gains of as much as 503%.
Naturally, most of the headlines are focused on these unbelievable movements.
But there’s been another, far less heralded short squeeze name that shot up this week that you need to be aware of.
It shows us that enormous gains can be made from more than just GME and AMC. And I’ve got my eye on another stock that could be the next big short squeeze opportunity.
Where’s the money?
While AMC and GME garnered most of the headlines over the last week, another stock was quietly making a small fortune for investors with long positions.
Starting on Monday morning, Clover Health Investments, Corp. (CLOV) has boomed as high as 221% over Friday’s close.
This Medicare Advantage insurer has had as much as 37% short interest, giving it great squeeze potential. It’s a stock that has been showing up on my Super Squeeze Profits watchlist for a while now.
In fact, because S.C.A.N. was able to identify huge order flow ahead of the crowd, subscribers just had the opportunity this week to score an unbelievable 313% profit in CLOV call options I recommended to them on April 30.
Now that Clover is starting to get some traction in the media, there are a lot of investors with FOMO that want to know if they should still get into the latest short squeeze, or if this move has run its course.
Here’s what I’m seeing…
How do I get some?
Investors in CLOV had a huge win this week.
And yes, I think the short squeeze is still on.
But after such a gigantic move up, I think we’re going to see a lot of traders taking profits in CLOV and moving to the next trade. If we see a significant enough dip in CLOV, I may advise to buy back in, but right now there’s another great opportunity that has my attention.
Weibo Corporation (WB) is one of my favorite names in the short squeeze space. A number of Chinese tech companies have attracted a lot of short positions amid the government’s crackdown on tech firms.
Short interest has been on the rise for WB – increasing by 64.5% since January. This is a stock that will likely be on my next Super Squeeze Profits watchlist, and could pop at any time.
I’d recommend taking a good look at this stock if you’re looking to put some speculative capital towards short squeeze trades.
But if you want to maximize your profits from this kind of trading, I’ve got just the thing for you…
Supercharge Your Short Squeeze Gains
The last few months have given us plenty of examples of the potential for huge moves from the market’s most heavily shorted stocks.
But the stocks are just a part of the story.
In order to maximize the potential for gigantic profits, I’m using the leveraged power of options to increase those gains to epic levels – like the 313% profit on CLOV that Super Squeeze Profits subscribers just had the chance to take this week after a little over a month of holding.
And it’s not too late to get in on the hottest trend on Wall Street. I’m seeing a myriad of new profit opportunities on the horizon.
But you can only get my next recommendation if you’re a Super Squeeze Profits member.
Ready to take your short squeeze trading to the next level. Click here, and I’ll show you exactly how you can get in on the next squeeze before the crowd.
In the Spotlight: In other short squeeze news…
While the short squeeze craze has made fortunes for investors already, that’s far from the only effect the movement is having.
In fact, an enormous impact could be felt on Wall Street for years to come.
On Wednesday, SEC chairman Gary Gensler announced that he’s tasked his agency with investigating issues with trading that have come to light as a result of the short squeeze mania and the rise of retail investors.
Market trading rules involving the speed at which trades are settled and the payment-for-order-flow system are being put under the microscope.
Trade settlement could be accelerated to as little as the same day, which would help to even the playing field between retail investors and big Wall Street institutions by providing trading data to retail investors faster.
While it’s unclear what the SEC would do to change the rising amount of inefficient fill prices from the payment-for-order-flow system, but they are clearly looking for ways to appease the growing complaints from retail investors.
This is a massive story for the market, and I’ll be eagerly awaiting any rules changes from the SEC. And of course, I’ll be sure to share with you the impact of any changes that may come to fruition. Stay tuned.